Our team (only partially listed here), including several Venture Partners, consists primarily of entrepreneurs, some of them scientists, who have (co-)founded companies in different industries, collectively valued at more than 1bn €.



Michael Weidner

Founding Partner



+49 89 99950912

Mail: first letter of forename + first letter of surname @alchemylabs.vc


Michael strives to combine profitable entrepreneurship with maximum technological, and therefore, societal impact.
He started his first full business aged 23 in the – then profitable – renewable energy industry and achieved more than € 1mn in sales in just two years.

Since 2015 his field of operations is deep-science venture creation, where he got broad insights and experience in a wide range of areas and operational questions how to find promising technologies and make businesses out of them.
Michael holds a degree in Business Administration/Technology&Innovation Management from the University of Bayreuth and is very technology-oriented.



Currently undisclosed Partner

Founding Partner, primarily responsible for Strategy & Venture Capital


Seasoned entrepreneur with track-record in setting up (very) valueable businesses

Dr. Valentin Kahl

Venture Partner


Valentin is one of the four founders and CEO of ibidi GmbH, a leading provider of innovative functional cell-based assay technologies. Founded as a spin-off from LMU/TU Munich in 2001, ibidi became one of Germany's most successful enabling-technology biotech companies. ibidi received the 2012/2013 German Economy Innovation Award and has more than 60 employees today.

Valentin holds a PhD in Biophysics from TU Munich.

Current Advisory Board


Richard Henderson - Managing Partner at MTI Ventures (UK)


After operational roles in industry, Richard has been working with MTI on outstanding research commercialisation since 2001. MTI is an intellectual property investment and company building business, that also manages the £32m UMIP Premier Fund (est. 2008), targeting the University of Manchester and others. The UPF has made investments in areas like novel materials, engineering, energy storage, water, medical diagnostics and IT hardware. The fund’s capital deployment has leveraged £100m of co-investment and has recruited star management from the UK and Europe. Significant exits were realised.